QTRX
QTRX
NASDAQ · Life Sciences Tools & Services

Quanterix Corp

$3.55
+0.03 (+0.85%)
As of Apr 1, 2:11 PM ET ·
Financial Highlights (FY 2026)
Revenue
163.83M
Net Income
-126,385,880
Gross Margin
46.8%
Profit Margin
-77.1%
Rev Growth
+9.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.8% 46.8% 49.1% 49.1%
Operating Margin -90.4% -81.3% 5.5% 6.4%
Profit Margin -77.1% -73.3% 6.1% 4.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 163.83M 149.48M 208.12M 186.61M
Gross Profit 76.62M 69.91M 102.12M 91.57M
Operating Income -148,068,552 -121,589,139 11.39M 11.88M
Net Income -126,385,880 -103,784,025 12.69M 8.67M
Gross Margin 46.8% 46.8% 49.1% 49.1%
Operating Margin -90.4% -81.3% 5.5% 6.4%
Profit Margin -77.1% -73.3% 6.1% 4.6%
Rev Growth +9.6% +9.6% +19.2% -2.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 136.63M 133.70M
Total Equity 229.88M 201.96M
D/E Ratio 0.59 0.66
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -123,841,063 -107,343,987 15.93M 14.55M
Free Cash Flow 9.96M 8.22M